At Dow, we are applying our deep knowledge in chemistry, physics and material sciences to breakthrough solutions that contribute to human progress while driving growth for our Company. By strategically aligning our R&D investments to global megatrends that together represent more than $350 billion in addressable market opportunities, our innovations are creating value for our customers, society and shareholders.

Solutions At Work

  • Innovations commercializing today and poised to accelerate
  • Pipeline NPV at $33 billion, on a non-risk-adjusted NPV
  • ~$2 billion EBITDA expected from innovations by 2015

With a net present value of $33 billion, our innovation investments are enabling customers and shareholders to realize the benefits of the game-changing products and technologies we are bringing to market. In fact, our diversified, industry-leading pipeline of technology-based products has more than tripled in value in the last five years on a non-risk-adjusted net present value (NPV).

R&D Pipeline Evolution

Since 2009, Dow has delivered $400 million in EBITDA from innovation. We expect to reach a cumulative $2 billion in EBITDA by 2015. Breakthrough technologies, including ENLIGHT™ Polyolefin Encapsulant Films, EVOQUE™ Pre-Composite Polymer Technology and REFUGE ADVANCED® powered by SMARTSTAX®, are bringing value to our customers and our bottom line.

2011 R&D Pipeline Valuation by Stage


The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements made by or on behalf of The Dow Chemical Company and its subsidiaries (the Company). The forward-looking statements contained in this web site involve risks and uncertainties that may affect the Company's operations, markets, products, services, prices, and other factors as discussed in filings with the U.S. Securities and Exchange Commission (SEC). These risks and uncertainties include, but are not limited to, economic, competitive, legal, governmental, and technological factors. Accordingly, there is no assurance that the Company's expectations will be realized. The Company assumes no obligation to provide revisions to any forward-looking statements should circumstances change, except as otherwise required by securities and other applicable laws.

Dow Chemical (DOW)

Investor Communications